HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+5.41%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$141M
AUM Growth
+$141M
(+4.8%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
55.72%
Holding
161
New
36
Increased
33
Reduced
7
Closed
45
Top Buys
Top Sells
| 1 |
IPHI
INPHI CORPORATION
IPHI
|
$3.84M |
| 2 |
RP
RealPage, Inc.
RP
|
$3.37M |
| 3 |
iShares MSCI India ETF
INDA
|
$2.29M |
| 4 |
Genworth Financial
GNW
|
$1.92M |
| 5 |
Alibaba
BABA
|
$1.83M |
Sector Composition
| 1 | Technology | 32.85% |
| 2 | Healthcare | 32.22% |
| 3 | Financials | 6.7% |
| 4 | Communication Services | 6.68% |
| 5 | Consumer Discretionary | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
151
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-19,804
| Closed | -$677K |
|
|
KRON
152
DELISTED
Kronos Bio
KRON
| – | – |
-26,944
| Closed | -$789K |
|
153
Neurogene
NGNE
$284M
| – | – |
-71,235
| Closed | -$877K |
|
154
Novo Nordisk
NVO
$252B
| – | – |
-5,113
| Closed | -$345K |
|
155
Oric Pharmaceuticals
ORIC
$1.03B
| – | – |
-22,333
| Closed | -$547K |
|
156
Ovid Therapeutics
OVID
$94.6M
| – | – |
-40,920
| Closed | -$164K |
|
157
Avidity Biosciences
RNA
$6.12B
| – | – |
-31,797
| Closed | -$693K |
|
158
Rhythm Pharmaceuticals
RYTM
$6.75B
| – | – |
-24,809
| Closed | -$528K |
|
|
SAGE
159
DELISTED
Sage Therapeutics
SAGE
| – | – |
-10,111
| Closed | -$757K |
|
160
Southern Copper
SCCO
$82B
| – | – |
-3,800
| Closed | -$258K |
|
161
Solid Biosciences
SLDB
$448M
| – | – |
-91,557
| Closed | -$506K |
|